Collectively, these findings demonstrate that APS mitigate DN progression by enhancing autophagy and suppressing renal fibrosis through targeted modulation of the lncRNA-Gm41268/PRLR signaling pathway. The gene discussed is PRLR; the disease is autoimmune polyendocrinopathy.